Washington University Institute of Clinical and Translational Sciences Receives $61 Million in Funding

Image Credit
Matt Miller, Washington University School of Medicine in St. Louis
Washington University ICTS Director William G. Powderly, MD, (right) discusses patient conditions in the intensive care unit with Maanasi Samant, MD, at Barnes-Jewish Hospital during the pandemic.

Washington University School of Medicine in St. Louis has received a $61 million grant from the National Center for Advancing Translational Sciences of the National Institutes of Health (NIH) to support the infrastructure for developing and carrying out biomedical research studies. The funding supports Washington University’s Institute of Clinical and Translational Sciences (ICTS), which was established in 2007. The five-year grant renewal ensures that the ICTS will continue to serve as an engine of innovation in clinical and translational research across Missouri, with a focus on precision health, equity and diversity.

CTSA Program In Action Goals
Goal 1: Train and Cultivate the Translational Science Workforce
Goal 2: Engage Patients and Communities in Every Phase of the Translational Process
Goal 3: Promote the Integration of Special and Underserved Populations in Translational Research Across the Human Lifespan
Goal 4: Innovate Processes to Increase the Quality and Efficiency of Translational Research, Particularly of Multisite Trials
Goal 5: Advance the Use of Cutting-Edge Informatics